等待開盤 03-26 09:30:00 美东时间
+0.030
+0.52%
今日重点评级关注:Freedom Capital Markets:维持LifeMD"买入"评级,目标价从8美元升至10美元;Chardan Capital:维持Opus Genetics"买入"评级,目标价从9美元升至11美元
03-13 09:59
Citizens analyst Patrick Walravens maintains Sprinklr (NYSE:CXM) with a Market Outperform and lowers the price target from $17 to $11.
03-12 20:35
Sprinklr beat earnings and revenue estimates for Q4, with subscription revenue reaching $193.4M. The company also announced a $125M accelerated share repurchase.
03-11 23:42
Companies Reporting Before The Bell • Sprinklr (NYSE:CXM) is estimated to repor...
03-11 19:11
Sprinklr (NYSE:CXM) is looking for Q1 Adj EPS of $0.09 vs $0.12 analyst estimate. sees sales of $215.500 million-$216.500 million vs $214.538 million analyst estimate.
03-11 19:07
Sprinklr (NYSE:CXM) is looking for FY2027 Adj EPS of $0.47-$0.48 vs $0.47 analyst estimate. sees sales of $869.000 million-$871.000 million vs $882.913 million analyst estimate.
03-11 19:07
Sprinklr (NYSE:CXM) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.10 by 35.42 percent. This is a 30 percent increase over earnings of $0.10 per share from the same period
03-11 19:06
Sprinklr to release Q1 earnings on March 11, expected to report 10 cents/share. Analysts have mixed ratings, with $17 as highest target price.
03-11 14:47
Sprinklr (NYSE:CXM) is preparing to release its quarterly earnings on Wednesday...
03-10 22:02
Shares of software companies are trading lower after Citrini Research published...
02-24 04:32